Toxicity-guided Dosing
Toxicity-Guided Dosing is a dose adjustment method in oncology that tailors drug administration regimens based on individual patient toxicity responses, distinguishing itself from fixed-dose or body surface area–based approaches by prioritizing real-time safety and tolerability assessments to optimize therapeutic outcomes.
31
Publications
1.6K
Citations
229
Authors
111
Institutions
Publications per year
2017–2026
9
31
Ann H. Partridge, Laura Archer, Alice B. Kornblith et al. · Journal of Clinical Oncology · 2010 · 127 citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17
Sophie Postel‐Vinay, Laurence Collette, Xavier Paolettí et al. · European Journal of Cancer · 2014 · 122 citations
Medicine, Oncology, Pharmacology +17
1–5 of 31
229
2
h-index
European Organisation for Research and Treatment of Cancer, Belgium
2 publications · 198 citations
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 229
111
University of Chicago
Chicago, United States
3 h-index
15 publications
1.2K citations

Institut Curie
Paris, France
3 h-index
6 publications
424 citations
Inserm
Paris, France
3 h-index
8 publications
684 citations
National Cancer Institute
Bethesda, United States
3 h-index
3 publications
255 citations
The University of Texas MD Anderson Cancer Center
Houston, United States
2 h-index
9 publications
2.3K citations
Emory University
Atlanta, United States
2 h-index
3 publications
105 citations

Princess Margaret Cancer Centre
Toronto, Canada
2 h-index
2 publications
198 citations
Spanish National Cancer Research Centre
Madrid, Spain
2 h-index
2 publications
198 citations
1–8 of 111
4 publications · 205 citations
4
h-index
2 publications · 198 citations
2
h-index
2 publications · 131 citations
2
h-index
2 publications · 104 citations
2
h-index
2 publications · 100 citations
2
h-index
1–5